The Saudi Mouth — Part 4: The Sixth Complication

Saudi Arabia has a 23.1% adult diabetes prevalence. Over half of Saudi adults have periodontitis. The two conditions are biologically linked in both directions — and treating gum disease measurably improves glycemic control. Here is the evidence.

Research

By Dr. Mahmoud H. Al-Johani

Periodontitis, Diabetes, and What Happens When Saudi Arabia's Two Epidemics Meet

Saudi Arabia is living through two epidemics at once.

The first is diabetes. With a prevalence of 23.1% among adults — 5.3 million people — Saudi Arabia ranks among the highest in the world for type 2 diabetes burden.¹ The International Diabetes Federation projects that number will nearly double to 9.5 million by 2050.¹ This is not a background statistic. It is the single most clinically significant comorbidity that a Saudi dental professional will encounter in daily practice, with near-certainty, multiple times per week.

The second epidemic is periodontal disease. A 2024 systematic review found that more than half of Saudi adults — 52.1% — suffer from periodontitis.² Severe periodontitis is the sixth most common disease globally, affecting an estimated 1.1 billion people.

What most patients do not know — and what a significant proportion of clinicians have not fully integrated into practice — is that these two epidemics are not independent. They are biologically linked in both directions. Diabetes worsens periodontal disease. Periodontal disease worsens diabetes. And treating one measurably improves the other.

This is Part 4 of The Saudi Mouth.

The Relationship, Direction One: Diabetes Worsens the Mouth

Diabetes has been recognized as a major risk factor for periodontal disease for decades. The mechanism is well established.

Chronic hyperglycemia drives the accumulation of advanced glycation end-products (AGEs) in periodontal tissues. AGEs bind to their receptors (RAGE) on macrophages, endothelial cells, and fibroblasts — triggering a proinflammatory cascade that is amplified and sustained in a way that does not occur in normoglycemic patients. The result: exaggerated local tissue destruction in response to the same bacterial challenge that a non-diabetic patient's periodontium would handle more effectively.

Hyperglycemia also impairs neutrophil function — the first-line cellular defense against periodontal pathogens. Collagen synthesis is disrupted. Wound healing is delayed. The vascular changes of diabetes reduce oxygen and nutrient delivery to the periodontal ligament. Every aspect of the tissue's ability to defend itself and repair is compromised by the glycemic environment.

The quantified risk: a systematic review and meta-analysis found that diabetes increases the risk of developing or progressing periodontitis by 86% (RR 1.86, 95% CI 1.3–2.8).³ People with diabetes have approximately a threefold increased susceptibility to periodontitis.⁴ A Saudi-specific systematic review published in Cureus in 2024 found a periodontitis prevalence of 46.4% among type II diabetic patients in Saudi Arabia.⁵

Nearly half of Saudi patients with type 2 diabetes have periodontitis. In a country where 5.3 million adults have diabetes, that is sitting in your waiting room.

The Relationship, Direction Two: The Mouth Worsens Diabetes

The bidirectionality is the part that changes clinical thinking.

Periodontitis is not merely a passive victim of systemic disease. It is an active contributor to it. Chronic periodontal infection maintains a state of systemic low-grade inflammation — elevated serum IL-6, TNF-α, and C-reactive protein. This inflammatory burden interferes directly with insulin signaling, impairing glucose uptake at the cellular level and worsening insulin resistance.

A 2021 prospective cohort meta-analysis confirmed a positive bidirectional association across 17 cohort studies.⁶ For patients with periodontitis, the data showed a 24% increased incidence of diabetes (95% CI: 13–37%).⁷ For patients with diabetes, periodontitis incidence increased by 24% as well.⁷

In plain terms: your diabetic patient's uncontrolled gum disease is actively making their diabetes harder to manage. And your periodontitis patient with undiagnosed prediabetes may have an oral infection contributing to the trajectory toward a diabetes diagnosis.

This is not a theory. It is documented in prospective data.

The Treatment Evidence: What Periodontal Therapy Does to HbA1c

This is the section that should change what a dentist tells every diabetic patient at the start of treatment.

Multiple systematic reviews and meta-analyses have established that non-surgical periodontal therapy produces a statistically significant reduction in HbA1c in patients with type 2 diabetes.

A 2025 meta-analysis showed a mean HbA1c reduction of 0.64% at three months following periodontal treatment.⁸ An umbrella review reported mean HbA1c reductions of 0.49% at 3 months and 0.38% at 6 months.⁹ A further review confirmed a 0.5% reduction at six months with thorough periodontal therapy.

To put that in clinical context: a 0.5% reduction in HbA1c is meaningful. It is in the range of some oral hypoglycemic medications. Scaling and root planing — a procedure that dental professionals perform routinely — produces measurable, documented improvement in glycemic control in diabetic patients.

This evidence reframes the periodontal appointment. It is not just oral hygiene maintenance. In a diabetic patient, it is part of their diabetes management.

The Saudi Context: Where Both Epidemics Collide

Saudi Arabia sits at the intersection of both epidemics at an extreme level.

Diabetes prevalence at 23.1% is among the highest globally.¹ Periodontitis prevalence at over 52% among adults means that in any given clinic day, a Saudi dentist will see multiple patients carrying both conditions simultaneously — often with neither fully managed, and with no communication between the dental provider and the endocrinologist or GP managing the diabetes.

The 2024 Cureus systematic review noted that periodontal disease prevalence was significantly higher in Saudi diabetic patients than non-diabetics, independent of oral hygiene status — meaning good brushing habits did not eliminate the systemic risk.⁵

A Saudi study on pregnancy outcomes found a significant association between periodontal disease and adverse pregnancy outcomes including preterm birth and low birth weight — directly relevant to the substantial proportion of Saudi dental patients who are women of reproductive age with gestational diabetes.¹⁰

The dental professional in Saudi Arabia is uniquely positioned to intercept a systemic disease burden that the broader healthcare system is struggling to contain. A dentist who identifies severe untreated periodontitis in a patient without a recent HbA1c check, and coordinates with that patient's physician, is doing something clinically significant beyond the oral cavity.

What This Means at the Chair

Ask about diabetes at every new patient intake — and update at every recall. Not "do you have any medical conditions?" but specifically: "Have you been diagnosed with diabetes or prediabetes? When was your last HbA1c?" The diabetic patient presenting for routine dental care may have poorly controlled or newly diagnosed disease. The dental history is an opportunity to identify who needs a referral.

Explain the bidirectional link to every diabetic patient in plain language. "Your gum disease and your diabetes affect each other. Treating your gums can help improve your blood sugar control. It is not a replacement for your diabetes medications — but it is part of managing your overall health." This takes thirty seconds. Most patients have never heard it.

Set realistic expectations for periodontal healing in uncontrolled diabetics. A patient with HbA1c above 9% will have impaired healing, higher susceptibility to infection, and slower resolution of inflammation. Treatment phasing and more frequent recall are clinically justified.

Recognize the oral warning signs of undiagnosed diabetes. Heavy calculus disproportionate to plaque, rapidly progressive bone loss, poor healing after routine procedures, recurrent periodontal abscesses — these can be early clinical signals. Document, flag, and refer.

Communicate with medical colleagues. A letter to the patient's GP stating "your patient presented with Stage III periodontitis and has received non-surgical periodontal therapy; evidence supports that this may assist in glycemic control" positions the dental team as a legitimate partner in systemic care — because it is.

Key Takeaways

  1. Saudi Arabia has a 23.1% adult diabetes prevalence — 5.3 million people, projected to reach 9.5 million by 2050. Periodontitis affects over 52% of Saudi adults.
  2. Diabetes increases the risk of periodontitis by 86%. Saudi type II diabetic patients have a periodontitis prevalence of approximately 46.4%.
  3. The relationship is bidirectional. Periodontitis worsens insulin resistance. Patients with periodontitis have a 24% increased incidence of developing diabetes.
  4. Non-surgical periodontal therapy reduces HbA1c by 0.5–0.64% in type 2 diabetic patients — comparable to the effect size of some oral hypoglycemic agents.
  5. The Saudi dentist is positioned at the intersection of two of the country's largest disease burdens. Asking about diabetes, treating periodontitis thoroughly, and communicating with medical colleagues is not just good dental practice — it is good healthcare.

References

  1. IDF Diabetes Atlas 2024 — Saudi Arabia. https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/saudi-arabia/
  2. Periodontal disease in Saudi Arabia — systematic review. MDPI Diagnostics. 2024. https://www.mdpi.com/2075-4418/15/7/812
  3. Diabetes increases periodontitis risk by 86%. Systematic review and meta-analysis. https://vbn.aau.dk/en/publications/does-diabetes-increase-the-risk-of-periodontitis-a-systematic-rev/
  4. Periodontitis and diabetes: threefold susceptibility. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC3228943/
  5. Epidemiology of periodontal diseases in individuals with diabetes in Saudi Arabia. Cureus. 2024. PMID: 39318963. https://pubmed.ncbi.nlm.nih.gov/39318963/
  6. Bidirectional association between periodontal disease and diabetes — cohort meta-analysis. PMC. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8249442/
  7. 24% bidirectional incidence increase. Nature Scientific Reports. 2021. https://www.nature.com/articles/s41598-021-93062-6
  8. Periodontal treatment reduces HbA1c by 0.64% at 3 months. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11893427/
  9. Umbrella review: HbA1c reduction 0.49% at 3 months, 0.38% at 6 months. ResearchGate. https://www.researchgate.net/publication/364410010
  10. Periodontal disease and adverse pregnancy outcomes in Saudi Arabia. PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11141704/

The Saudi Mouth is a SaudiDent original series by Dr. Mahmoud H. Al-Johani. Part 1 — Our Children's Teeth: https://saudident.com/blog/our-childrens-teeth-dental-caries-saudi-arabia Part 2 — The Shisha Session: https://saudident.com/blog/the-saudi-mouth-shisha-waterpipe-oral-health Part 3 — The Lesion You Should Not Miss: https://saudident.com/blog/the-saudi-mouth-oral-cancer-screening

Read on SaudiDent